Dr. Hetty Carraway is the director of the leukemia program and vice chair of strategy and enterprise development at Cleveland Clinic’s Taussig Cancer Institute, specializing in acute leukemias and myeloproliferative disorders. She is professor of medicine at Lerner college of medicine at case western reserve. She completed her medical training at Johns Hopkins University, where she also earned an MBA focused on the business of health. Board‑certified in internal medicine and medical oncology, Dr. Carraway is an active member of ASH, ASCO, AACR, and SWOG, and has authored numerous peer‑reviewed publications and book chapters. She is nationally recognized for her expertise in hematologic malignancies and her translational research in experimental therapeutics.